Sequential catalytic nanomedicine augments synergistic chemodrug and chemodynamic cancer therapy

Tumor microenvironment (TME)-specific nanocatalysts for augmented synergistic chemodrug and chemodynamic cancer therapy have been constructed, which feature an optimized effect on TME features. Systematic in vitro and in vivo tests have revealed the high therapeutic activity of the nanocatalysts for substantially suppressing tumor growth.